Hilton Worldwide: RevPAR Growth Encouraging; Still Watching Price And Long-Term Debt (HLT)

JHVEPhoto/iStock Editorial via Getty Images Investment Thesis: Hilton Worldwide Holdings has the potential for further long-term upside based on resiliency in RevPAR growth. In a previous article back in February, I made the argument that Hilton Worldwide Holdings (NYSE:HLT) might see some short-term consolidation over potentially slower RevPAR growth this year. However, I maintained that…

Read More

Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson’s Prospects

koto_feja Intro Annovis Bio (NYSE:ANVS) is set to report the results of its Phase 3 trial in early-stage Parkinson’s disease (PD) in the coming weeks. The company’s lead asset, buntanetap (formerly known as posiphen), is a translational inhibitor of alpha synucelein (associated with PD), amyloid precursor protein (Alzheimer’s), TDP-43 (ALS), and other proteins associated with…

Read More

Lamb Weston: Growth Prospects Remain Encouraging (NYSE:LW)

phive2015 Investment Thesis Lamb Weston’s (NASDAQ: NYSE:LW) revenue growth should benefit from moderating volume decline in the coming quarters as the company laps the divestiture of lower-performing product lines and businesses which began in Q2FY23. Moreover, channel destocking in international markets is also near completion, which should also give a boost to volumes. In addition,…

Read More